Management Associate: New Product Commercialization Corporate and Gov Customers @ (January 2015 - January 2015)
Management Associate: Key Account Management and US Women S Healthcare Marketing Team @ (January 2014 - January 2015)
Management Associate: US Essure Marketing Team, Women S Healthcare @ (January 2013 - January 2014)
MBA Candidate, Class of 2013 @ (September 2011 - May 2013)
MBA Intern, Managed Markets @ (May 2012 - August 2012)
Business Project Specialist @ (January 2009 - January 2011)
Operations Specialist: Total Medical Cost Project Manager - Rotation Iii @ (January 2008 - January 2009)
Service Leadership Program Associate @ (January 2006 - January 2009)
Operations Specialist: Production Services Manager - Rotation Ii @ (January 2007 - January 2008)
Operations Specialist: National Accounts Eligibility Team - Rotation I @ (January 2006 - January 2007)
Christopher Parker Education
RU
Master of Business Administration (Marketing, Management)
2011-2013
RU
Bachelor of Science (Management)
2002-2006
Christopher Parker Skills
Analysis
CRM
Competitive Analysis
Cross-functional Team Leadership
Data Analysis
Healthcare
Leadership
Leadership Development
Managed Care
Marketing
Medicaid
Oncology
Pharmaceutical Industry
Process Improvement
Sales
Six Sigma
Strategy
Team Leadership
Training
Cross Functional Team Leadership
Channel Strategy
Channel Marketing
Project Management
Christopher Parker Summary
Christopher Parker, based in New York, NY, US, is currently a Senior Director, Immunology Payer Strategy at Sobi - North America. Christopher Parker brings experience from previous roles at Sobi - North America, EQRx, TG Therapeutics, Inc. and Amgen. Christopher Parker holds a 2011 - 2013 Master of Business Administration in Marketing, Management @ RU. With a robust skill set that includes Analysis, CRM, Competitive Analysis, Cross-functional Team Leadership, Data Analysis and more. Christopher Parker has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Christopher Parker?
Find contact details for 700 million professionals.